Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03726671 · ClinicalTrials.gov registry record · NA

Choline Nutritional Status: Development of a Biomarker Panel

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
101
Enrollment target

NCT03726671 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 101 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03726671, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target

Study Summary

People who eat diets low in choline should deplete their choline (Cho) stores, and measurements of Cho pool size using isotope dilution should reflect this depletion. Investigators will identify a biomarker panel that correlates well with measured Cho pool size across the range of different degrees of depletion.The investigators propose that, as body stores of Cho diminish, cells and organs will reach the point when metabolism/function in the cell is altered, and that this will result in a progression of changes in biomarkers that reflect Cho status.

Interventions

  • OTHER 25% Cho diet
  • OTHER 50% Cho diet
  • OTHER 100% Cho diet

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2018-11-01
Est. Completion 2021-10-20
Phase NA

What the Registry Record Tells You About NCT03726671

The ClinicalTrials.gov registry entry for NCT03726671 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which 25% Cho diet is the first listed.

NCT03726671 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03726671 about?

NCT03726671 is a clinical study titled "Choline Nutritional Status: Development of a Biomarker Panel". People who eat diets low in choline should deplete their choline (Cho) stores, and measurements of Cho pool size using isotope dilution should reflect this depletion. Investigators will identify a biomarker panel that correlates well with measured Cho pool size across the range of different degrees ...

What is the current status of trial NCT03726671?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2018-11-01. Estimated completion is 2021-10-20.

What interventions are being tested in trial NCT03726671?

The interventions under investigation include: 25% Cho diet (OTHER), 50% Cho diet (OTHER), 100% Cho diet (OTHER).

Who is sponsoring clinical trial NCT03726671?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.